Matteo Casenghi
@mcasenghi
Interventional Cardiologist @ University of Rome “La Sapienza”
ID: 1224042518347702279
02-02-2020 18:51:08
81 Tweet
139 Takipçi
213 Takip Edilen
🆕 Part 2 of the challenging #heartfailure case shared by Saleh Altaf and Dr Owais H Dar is now online. A man in his 30s with a significant cardiac history and three hospitalisations in six months presented with acute decompensation of advanced HF. 🔍 Explore the decision-making
iHF at #EuroPCR 2025 – Mark your calendars! Join the conversation on solution-oriented, innovative approaches to #HeartFailure in our 3 dedicated sessions on improving heart function. See the detailed programme👉bit.ly/43169S8 #ImprovingHeartFunction Emanuele Barbato
📢Meet the #iHF Social Media Team: Amina Marta Belmonte Matteo Casenghi David Duncker Emanuele Gallinoro, MD, PhD Pasquale Paolisso Hatem Soliman, FRCP, FEACVI, FASE, FHEA Prof. Izabella Uchmanowicz, RN, PhD,MBA,FESC, FHFA They’ll be sharing all the latest on #heartfailure care & our initiative🤳. Follow them & tag your updates with #ImprovingHeartFunction to
🎥Key insights from the #ImprovingHeartFunction session on refractory #heartfailure at #EuroPCR with Jozef Bartunek and Marta Belmonte
This week several members of #ImprovingHeartFunction 🫀attended #EuroPCR 2025! Alexandre Mebazaa Emanuele Barbato Emanuele Gallinoro, MD, PhD Marta Belmonte Matteo Casenghi Learning to advance #heartfailuremanagement and #patientcare
💡Fast-track GDMT optimisation in #HFrEF? Let’s talk strategies with Emanuele Barbato, Giuseppe Rosano, Philipp Lurz & Alexandre Mebazaa! The 🆕 #ImprovingHeartFunction webinar brings you expert-led, practical insights to enhance therapy uptake and patient outcomes. 🗓️19 June 2025 18:00
🚫Therapeutic impasse? Not anymore. Refractory heart failure is becoming a catalyst for change — in strategy, in collaboration, and in outcomes. 🔍 Emanuele Barbato & Alexandre Mebazaa dive into the power of combining pharmacological advances with device-based therapies in a
🆕 New Journal Club! Jolie Bruno, M.D. & Alexandre Mebazaa Mebazaa break down the CONFIDENCE trial (published in the NEJM): 💊 Finerenone + Empagliflozin in CKD + T2D. 📖Study insights & results here👉bit.ly/45NrJMY
We hope you will join us for this unique new Course that will be based on real-world practice in trans-disciplinary care of #heartfailure patients! #ImprovingHeartFunction 2026 iheartfunction.com/improving-hear… Sabine Bleiziffer Emanuele Barbato Alexandre Mebazaa leclercq christophe Improving Heart Function (iHF)
At iHF 2026, join practical, hands-on sessions built around what truly matters: real-world cases, drug & device synergy, and actionable tips. Register today and start transforming heart failure management. Watch the video to hear directly from Alexandre Mebazaa brnw.ch/21wW0Dy
We’re delighted to present our clinical case from the Cardiology Unit at Sant’Andrea University Hospital, showcasing the multidisciplinary management of a patient with HFrEF and multiple Valvular Heart Diseases. A special thank you to the Improving Heart Function (iHF) (iHF) Educational